<DOC>
	<DOCNO>NCT00833638</DOCNO>
	<brief_summary>The purpose study determine day onset efficacy tadalafil dose once-a-day .</brief_summary>
	<brief_title>A Study Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Male least 18 year old , least 3month history erectile dysfunction ( ED ) . Anticipate adult female sexual partner study . Agree make least 4 sexual intercourse attempt female partner 4week runin phase without medication . Agree make least 1 sexual intercourse attempt per day female partner day 14 follow randomization ( minimum three attempt required period ) . Also agree make least 3 intercourse attempt day 514 follow randomization . Agree use ED treatment study 24 hour final study visit . Partner Female least 18 year old . Agree make least 4 sexual intercourse attempt male sexual study partner 4week runin phase without medication . Agree make least 1 sexual intercourse attempt per day male partner day 14 follow randomization Agree make least 3 intercourse attempt day 514 follow randomization . Previous current treatment tadalafil phosphodiesterase type 5 ( PDE5 ) inhibitor daily basis daily use . ED cause primary sexual disorder , untreated inadequately treat endocrine disease . History radical prostatectomy , pelvic surgery penile implant . Clinically significant penile deformity opinion investigator . Clinically significant renal insufficiency , hepatobiliary disease determine investigator . Glycosylated hemoglobin &gt; 11 % . Present chronic stable angina treat longacting nitrate , chronic stable angina require shortacting nitrate last 90 day , angina occur sexual intercourse last 6 month . Have significant cardiac condition describe protocol exclusion criterion . Have history significant central nervous system injury within last 6 month . Have history Human Immunodeficiency Virus infection . Have condition would interfere subject 's ability provide inform consent comply study instruction , would place subject increase risk , might confound interpretation study result . Currently receive treatment nitrate , cancer chemotherapy , antiandrogens ( except finasteride take Propecia Proscar , Avodart [ dutasteride ] ) . History drug , alcohol , substance abuse within past 6 month , assess investigator . Previously complete withdrawn study investigate tadalafil daily use . Received treatment within last 30 day drug receive regulatory approval indication time study entry . Prior ineffective treatment PDE5 inhibitor opinion investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Erectile Dysfunction</keyword>
</DOC>